Regulation of cell growth by muc1
CA 2432276 A1 · Owner: Kufe, Donald W. · Inventors: Kufe, Donald W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention features a method of identifying a compound that inhibits (a) the physical interaction (binding) between MUC1 and tumor progressors (e.g. .beta.-catening c-Src, EGF-R, p120ctn, or PKC.delta.) and/or (b) phosphorylation of MUC1 by tumor progressors with kinase activity (e.g. c- Src, EFG-R, or PKC.delta.). The invention also includes a method of inhibiting an interaction between MUC1 and .beta.-catening and a method of inhibiting expression of MUC1 or a tumor progressor in a cell.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 26, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.